FDA Includes Device Scenarios in GMP Guidance for Combo Products

The GMP Letter
A A
The FDA’s recently released final guidance on GMP requirements for combination products includes several compliance scenarios for prefilled syringes, drug-coated meshes and drug-eluting stents.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00